Incidence, ASIR, and Relative change of Tuberculosis in children and Adolescence in global and 21 regions, with EAPC from 1990 and 2021. by Xue Li (285380)

Subjects:

ASDR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

Temporal trends of tuberculosis ASIR by Xue Li (285380)

Subjects:

The incidence, death and DALYs in individuals aged 0 to 19 years in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

Composition ratio of each type of tuberculosis age-standardized incidence rate in 21 regions in 1990 and 2021. by Xue Li (285380)

Subjects:

Each types of tuberculosis ASMR in 1990 and 2021. by Xue Li (285380)

Subjects:

DALYs, ASDR, and Relative change of Tuberculosis in children and Adolescence in global and 21 regions, with EAPC from 1990 and 2021. by Xue Li (285380)

Subjects:

Age standardized incidence rates of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

Death number, ASMR under the age of 20 in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

ASMR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

Each types of tuberculosis ASDR in 1990 and 2021. by Xue Li (285380)

Subjects:

Each types of tuberculosis ASIR in 1990 and 2021. by Xue Li (285380)

Subjects:

Death, ASMR, and Relative change of Tuberculosis in children and Adolescence in global and 21 regions, with EAPC from 1990 and 2021. by Xue Li (285380)

Subjects:

Incidence, death and DALYs of TB, by age and sex in 2021. by Xue Li (285380)

Subjects:

Composition ratio of each types of tuberculosis ASDR in 1990 and 2021. by Xue Li (285380)

Subjects:

Incidence number, ASIR under the age of 20 in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

Composition ratio of each types of tuberculosis ASMR in 1990 and 2021. by Xue Li (285380)

Subjects:

DALYs number, ASDR under the age of 20 in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

Genomic downregulation of TGF β1 production in monocytes obtained after RZV administration. Panel A. The heatmap shows 16 genes on the y axis whose accessibility significantly chan... by Michael J. Johnson (5818168)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”